ABEO 8-K 2026-11-09

ABEONA THERAPEUTICS INC. (ABEO) 8-K dated 2026-11-09 — accession 0001493152-26-050606.

ABEONA THERAPEUTICS INC. (ABEO) is a biotechnology company listed on US.

ABEONA THERAPEUTICS INC. filed a 8-K on 2026-11-09. Accession 0001493152-26-050606.

This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ABEO revenue for 2025-12-31 was $5.8M. Net income was $71.2M. Revenue was up 37.1% from 2024-12-31 to 2025-12-31. ABEO currently screens at market cap $301.8M.

Not investment advice. The ABEO SEC hub lists recent forms. The stock page is the research view.